SphingoTec – Diagnosis and monitoring of critical medical conditions
SphingoTec's innovative diagnostics for critical care provide actionable insights in real-time and enable more timely and improved patient management.
SphingoTec develops and markets innovative in vitro diagnostic (IVD) tests for the diagnosis and monitoring of critical medical conditions. SphingoTec’s first-in-class biomarker tests are made available on its proprietary point-of-care Nexus IB10 platform for convenient and rapid testing in near-patient and laboratory settings. For high-throughput testing in central laboratories, SphingoTec partners with global IVD players.
Industry
Diagnostics
